As an RNA-binding protein, previous studies demonstrated that IGF2BP3-mediated targeting of oncogenic transcripts of Myc and CDK6 promotes hematopoietic progenitor proliferation in MLL-rearranged B-ALL [27]. This evidence concerns the gene IGF2BP3 and precursor B-cell acute lymphoblastic leukemia.